Lung Deposition Using the Respimat


Journal

COPD
ISSN: 1541-2563
Titre abrégé: COPD
Pays: England
ID NLM: 101211769

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 12 12 2020
medline: 25 11 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

Tiotropium and olodaterol are mainstay treatments for chronic obstructive pulmonary disease (COPD) and yield important clinical improvements, especially when used in fixed-dose combination. Whilst previous studies have shown consistent delivery of tiotropium to the lungs with the Respimat

Identifiants

pubmed: 33302718
doi: 10.1080/15412555.2020.1853091
doi:

Substances chimiques

Benzoxazines 0
Bronchodilator Agents 0
Tiotropium Bromide XX112XZP0J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-100

Auteurs

Anna-Maria Ciciliani (AM)

Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Mainz, Germany.

Mark Denny (M)

Respiratory Drug Delivery, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.

Peter Langguth (P)

Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Mainz, Germany.

Thomas Voshaar (T)

Stiftung Krankenhaus Bethanien, Moers, Germany.

Herbert Wachtel (H)

Analytical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH